Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Can visuospatial measures improve the diagnosis of Alzheimer's disease?

Salimi S, Irish M, Foxe D, Hodges JR, Piguet O, Burrell JR.

Alzheimers Dement (Amst). 2017 Nov 6;10:66-74. doi: 10.1016/j.dadm.2017.10.004. eCollection 2018. Review.

2.

Spatiotemporal Propagation of the Cortical Atrophy: Population and Individual Patterns.

Koval I, Schiratti JB, Routier A, Bacci M, Colliot O, Allassonnière S, Durrleman S.

Front Neurol. 2018 May 4;9:235. doi: 10.3389/fneur.2018.00235. eCollection 2018.

3.
4.

Human Neurospheroid Arrays for In Vitro Studies of Alzheimer's Disease.

Jorfi M, D'Avanzo C, Tanzi RE, Kim DY, Irimia D.

Sci Rep. 2018 Feb 5;8(1):2450. doi: 10.1038/s41598-018-20436-8.

5.

Temporal gradient during famous face naming is associated with lower cerebral blood flow and gray matter volume in aging.

Hays CC, Zlatar ZZ, Campbell L, Meloy MJ, Wierenga CE.

Neuropsychologia. 2017 Dec;107:76-83. doi: 10.1016/j.neuropsychologia.2017.11.011. Epub 2017 Nov 10.

PMID:
29133109
6.

Personality Change in the Preclinical Phase of Alzheimer Disease.

Terracciano A, An Y, Sutin AR, Thambisetty M, Resnick SM.

JAMA Psychiatry. 2017 Dec 1;74(12):1259-1265. doi: 10.1001/jamapsychiatry.2017.2816.

PMID:
28975188
7.

Cognitive Trajectory Changes Over 20 Years Before Dementia Diagnosis: A Large Cohort Study.

Li G, Larson EB, Shofer JB, Crane PK, Gibbons LE, McCormick W, Bowen JD, Thompson ML.

J Am Geriatr Soc. 2017 Dec;65(12):2627-2633. doi: 10.1111/jgs.15077. Epub 2017 Sep 21.

PMID:
28940184
8.

Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Ginsberg SD, Malek-Ahmadi MH, Alldred MJ, Che S, Elarova I, Chen Y, Jeanneteau F, Kranz TM, Chao MV, Counts SE, Mufson EJ.

Hippocampus. 2017 Sep 9. doi: 10.1002/hipo.22802. [Epub ahead of print]

PMID:
28888073
9.

A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS.

Alzheimers Dement (Amst). 2017 May 30;8:147-155. doi: 10.1016/j.dadm.2017.05.003. eCollection 2017.

10.

Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort.

Baker E, Iqbal E, Johnston C, Broadbent M, Shetty H, Stewart R, Howard R, Newhouse S, Khondoker M, Dobson RJB.

PLoS One. 2017 Jun 7;12(6):e0178562. doi: 10.1371/journal.pone.0178562. eCollection 2017.

11.

How Does Psychosocial Behavior Contribute to Cognitive Health in Old Age?

Wilson RS, Bennett DA.

Brain Sci. 2017 May 23;7(6). pii: E56. doi: 10.3390/brainsci7060056.

12.

Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior Characterization.

Yang C, Sun X, Tao W, Li X, Zhang J, Jia J, Chen K, Zhang Z.

Front Aging Neurosci. 2017 Jan 10;8:332. doi: 10.3389/fnagi.2016.00332. eCollection 2016.

13.

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife.

Zokaei N, Giehl K, Sillence A, Neville MJ, Karpe F, Nobre AC, Husain M.

Cortex. 2017 Mar;88:98-105. doi: 10.1016/j.cortex.2016.12.016. Epub 2016 Dec 24.

14.

Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior.

Soldan A, Pettigrew C, Moghekar A, Albert M; BIOCARD Research Team.

J Int Neuropsychol Soc. 2016 Nov;22(10):968-977.

15.

Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort.

Sánchez-Benavides G, Gispert JD, Fauria K, Molinuevo JL, Gramunt N.

Alzheimers Dement (Amst). 2016 Aug 30;4:149-158. eCollection 2016.

16.

Mild Cognitive Impairments Moderate the Effect of Time on Verbal Fluency Performance.

Demetriou E, Holtzer R.

J Int Neuropsychol Soc. 2017 Jan;23(1):44-55. doi: 10.1017/S1355617716000825. Epub 2016 Oct 17.

17.

[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.

Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC.

Clin Neuropsychol. 2017 Jan;31(1):99-117. doi: 10.1080/13854046.2016.1241303. Epub 2016 Oct 11.

18.

A longitudinal study of cognitive trajectories in Mexican Americans age 75 and older.

Downer B, Chen NW, Raji M, Markides KS.

Int J Geriatr Psychiatry. 2017 Oct;32(10):1122-1130. doi: 10.1002/gps.4575. Epub 2016 Sep 6.

19.

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.

Löwe LC, Gaser C, Franke K; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2016 Jul 13;11(7):e0157514. doi: 10.1371/journal.pone.0157514. eCollection 2016.

20.

Exposure to air pollution as a potential contributor to cognitive function, cognitive decline, brain imaging, and dementia: A systematic review of epidemiologic research.

Power MC, Adar SD, Yanosky JD, Weuve J.

Neurotoxicology. 2016 Sep;56:235-253. doi: 10.1016/j.neuro.2016.06.004. Epub 2016 Jun 18. Review.

Supplemental Content

Support Center